Laboratory capability and surveillance testing for middle east respiratory syndrome coronavirus infection in the who european region, June 2013

D. Pereyaslov, P. Rosin, D. Palm, H. Zeller, D. Gross, C. S. Brown, M. J. Struelens, Alma Robo, Iris Hasibra Hatibi, Josep Casals Alis, Shushan Sargsyan, Sadraddin Gurbanov, Natalia Gribkova, Marc Van Ranst, Greet Ieven, Sophie Patteet, Stanka Tomic, Neli Korsun, Vladimir Drazenovic, Despo Pieridou-BagkatzouniHelena Jirincova, Martina Havlickova, Anders Fomsgaard, KüLli Rae, Maija Lappalainen, Niina Ikonen, Bruno Lina, Sylvie Van Der Werf, Jean Claude Manuguerra, Ann Machablishvili, Markus Eickmann, Thorsten Wolff, Gerhard Dobler, Jonas Schmidt-Chanasit, Christian Drosten, Anna Papa, Andreas F. Mentis, Zoltan Kis, Arthur Löve, Suzie Coughlan, Michal Mandelboim, Maria R. Capobianchi, Maria Paola Landini, Fausto Baldanti, Giorgio Palu, Valeria Ghisetti, Isabella Donatelli, Gaukhar Nusupbayeva, Zarina Tokhtabakiyeva, Kaliya Kasymbekova, Jelena Storozenko, Sabine Erne, Algirdas Griskevicius, Matthias Opp, Christopher Barbara, Zoran Vratnica, Chantal Reusken, Susanne Gjeruldsen Dudman, Olav Hungnes, Katarzyna Pancer, Raquel Guiomar, Veronica Eder, Emilia Lupulescu, Svetlana Yatsyshina, Maria Pisareva, Zhanna Buzitskaya, Alexander Sergeev, Jasminka Nedeljković, Edita Staroňová, Tatjana Avšič Županc, Miroslav Petrovec, Miša Korva, Katarina Prosenc, Inmaculada Casas, Inmaculada Casas, Hans Gaines, Pascal Cherpillod, Niginamo Zakirova, Golubinka Bosevska, Basak Altas, Meral Ciblak, Meral Ciblak, Alla Mironenko, Tetiana Dykhanovska, Iryna Demchyshyna, Alison Bermingham, Ravshan Rakhimov

Research output: Contribution to journalArticlepeer-review

Abstract

Since September 2012, over 90 cases of respiratory disease caused by a novel coronavirus, now named Middle East respiratory syndrome coronavirus (MERS-CoV), have been reported in the Middle East and Europe. To ascertain the capabilities and testing experience of national reference laboratories across the World Health Organization (WHO) European Region to detect this virus, the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe conducted a joint survey in November 2012 and a follow-up survey in June 2013. In 2013, 29 of 52 responding WHO European Region countries and 24 of 31 countries of the European Union/European Economic Area (EU/EEA) had laboratory capabilities to detect and confirm MERS-CoV cases, compared with 22 of 46 and 18 of 30 countries, respectively, in 2012. By June 2013, more than 2,300 patients had been tested in 23 countries in the WHO European Region with nine laboratory-confirmed MERS-CoV cases. These data indicate that the Region has developed significant capability to detect this emerging virus in accordance with WHO and ECDC guidance. However, not all countries had developed capabilities, and the needs to do so should be addressed. This includes enhancing collaborations between countries to ensure diagnostic capabilities for surveillance of MERS-CoV infections across the European Region.

Original languageEnglish
Article number20923
JournalEuro surveillance : bulletin européen sur les maladies transmissibles = European communicable disease bulletin
Volume19
Issue number40
Publication statusPublished - Oct 9 2014

ASJC Scopus subject areas

  • Epidemiology
  • Public Health, Environmental and Occupational Health
  • Virology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Laboratory capability and surveillance testing for middle east respiratory syndrome coronavirus infection in the who european region, June 2013'. Together they form a unique fingerprint.

Cite this